Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. (2021)
Attributed to:
Molecular origins of metastatic cancer phenotypes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s43018-021-00221-9
PubMed Identifier: 35121945
Publication URI: http://europepmc.org/abstract/MED/35121945
Type: Journal Article/Review
Volume: 2
Parent Publication: Nature cancer
Issue: 7
ISSN: 2662-1347